Interaction of pyridostigmine bromide and N,N-diethyl-m-toluamide alone and in combination with P-glycoprotein expressed in Escherichia coli leaky mutant

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 69, Issue 10, 2006, Pages 919-933

  El Masry, Eman ^a   Abou Donia, Mohamed ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; DAUNORUBICIN; DIETHYLTOLUAMIDE; GLYCOPROTEIN P; IODOARYLAZIDOPRAZOSIN; LACTOSE PERMEASE; PRAZOSIN; PYRIDOSTIGMINE; RESERPINE; UNCLASSIFIED DRUG; CHOLINESTERASE INHIBITOR; COTRANSPORTER; ESCHERICHIA COLI PROTEIN; GLUCOSE TRANSPORTER; INSECT REPELLENT; LACY PROTEIN, E COLI;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BACTERIUM MUTANT; CELL GROWTH; CHEMICAL INTERACTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; ESCHERICHIA COLI; GENE; GENETIC TRANSFORMATION; HYDROLYSIS; IN VITRO STUDY; INHIBITION KINETICS; MDR1 GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; TOXICITY TESTING; WESTERN BLOTTING; BIOSYNTHESIS; DRUG EFFECT; DRUG INTERACTION; GENETICS; METABOLISM; PLASMID;

ESCHERICHIA COLI;

CHOLINESTERASE INHIBITORS; DEET; DRUG INTERACTIONS; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; GENES, MDR; INSECT REPELLENTS; MONOSACCHARIDE TRANSPORT PROTEINS; P-GLYCOPROTEIN; PLASMIDS; PYRIDOSTIGMINE BROMIDE; SYMPORTERS;

EID: 33745372771     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287390500360588     Document Type: Article

References (60)

1. Abdel-Rahman A. A., Shetty, A. K., and Abou-Donia, M. B. 2001. Subchronic dermal application of N,N-diethyl-m-toluamide (DEET) and permethrin to adult rats, alone or in combination, causes diffuse neuronal cell death and cytoskeletal abnormalities in the cerebellum. Exp. Neurol. 172:153-171.
2. Abdel-Rahman A. A., Abou-Donia, S., El-Masry, E. M., Shetty, A. K., and Abou-Donia, M. B. 2004a. Stress and combined exposure to low doses of pyridostigmine bromide, DEET, and permethrin produce neurochemical and neuropathological alterations in cerebral cortex, hippocampus, and cerebellum. J. Toxicol. Environ. Health A 67:163-192.
3. Abdel-Rahman, A., Dechkovskaia, A. M., Goldstein, L. B., Bullman, S. H., Khan, W., El-Masry, E. M., and Abou-Donia, M. B. 2004b. Neurological deficits induced by malathion, DEET, and permethern, alone or in combination in adult rats. J. Toxicol. Environ. Health A 67:331-356.
4. Abou-Donia, M. B., Wilmarth, K. R., Abdel-Rehman, A. A., Jensen, F. K., Oehme, F. W., and Kurt, T. L. 1996a. Increased neurotoxicity following concurrent exposure to pyridostigmine bromide, DEET, and chlorpyrifos. Fundam. Appl. Toxicol. 34:201-222.
5. Abou-Donia, M. B., Wilmarth, K. R., Jensen, F. K., Oehme, F. W., and Kurt, T. L. 1996b. Neurotoxicity resulting from coexposure to pyridostigmine bromide, DEET, and permethrin: Implications of Gulf War chemical exposure: Toxicol. Environ. Health 48:35-56.
6. Abou-Donia, M., El-Masry, E., and Abou-Qare, A. W. 2001a. Metabolism and toxicokinetics of xenobiotics. In CRC Handbook of Toxicology, eds. M. J. Derelanko and M. A. Hollinger, 2nd ed., pp. 757-821. Boca Raton, FL: CRC Press.
7. Abou-Donia, M. B., Goldstein, L. B., Jones, K. H., Abdel-Rehman, A. A., Damodaran, T. V., Dechkovskaia, A. M., Bullman, S. L., Amir, B. E., and Khan, W. A. 2001b. Locomotor and sensorimotor performance deficit in rats following exposure to pyridostigmine bromide, DEET, and permethrin, alone and in combination. Toxicol. Sci. 60:305-314.
8. Abou-Donia, M. B., Suliman, H. B., Khan, W. A., and Abdel-Rahman, A. A. 2003. Testicular germ-cell apoptosis in stressed rats following combined exposure to pyridostigmine bromide, N,N-diethyl-m-toluamide (DEET), and permethrin. J. Toxicol. Environ. Health A 66:57-73.
9. Abou-Donia, M. B., Dechkovskaia, A. M., Goldstein, L. B., Abdel-Rahman, A., Bullman, S. H., and Khan, W. A. 2004. Co-exposure to pyridostigmine bromide, DEET, and/or permethrin causes sensorimotor deficit and alterations in brain acetylcholinesterase activity. Pharmacol. Biochem. Behav. 77:253-262.
10. Abu-Qare, A. W., and Abou-Donia, M. B. 2001. DEET (N,N-diethyl-m- toluamide) alone and in combination with permethrin increased urinary excretion of β-hydroxycortisol in rats, a marker of hepatic CYP3A induction. J. Toxicol. Environ. Health A 64:373-384.
11. Abu-Qare, A. W., El-Masry, E. M., and Abou-Donia, M. B. 2003a. A role for P-glycoprotein in environmental toxicology. J. Toxicol. Environ. Health A 66:279-288.
12. Abu-Qare, A. W., Abdel-Rahman, A. A., and Abou-Donia, M. B. 2003b. Increased oral bioavailability of pyridostigmine bromide following a single dermal co-exposure to DEET and/or permethrin. Toxicologist 42:714.
13. Bain, L. J., and LeBlanc, G. A. 1996. Interaction of structurally diverse pesticides with the human MDR1 gene product P-glycoprotein. Toxicol. Appl. Pharmacol. 141(1):288-298.
14. Baynes, R. E., Halling, K. B., and Riviere, J. E. 1997. The influence of diethyl-m-toluamide (DEET) on the percutaneous absorption of permethrin and carbaryl. Toxicol. Appl. Pharmacol. 144:332-339.
15. Beja, O., and Bibi, E., 1996. Functional expression of mouse mdr1 in a membrane permeability mutant of E. coli. Proc. Natl. Acad. Sci. USA 93:5969-5974.
16. Bibi, E., Gros, P., and Kaback, H. R. 1993. Functional expression of mouse multidrug resistance protein in Escherichia coli. Proc. Natl. Acad. Sci. USA 90:9209-9213.
17. 14C-pyridostigmine in the rat. Br. J. Pharmacol. 26:393-402.
18. Blick, D. W., Kerenyi, S. Z., Miller, S., Murphy, M. R., Brown, G. C., and Hartgraves, S. L. 1991. Behavioral toxicity of anticholinesterase in primates: Chronic pyridostigmine and soman interactions. Pharmacol. Biochem. Behav. 38:527-532.
19. 14C-N,N-diethyl-m-toluamide in the animal body. Distribution and excretion after cutaneous application. Acta Pharmacol. Toxicol. 41:235-243.
20. Breyer-Pfaff, U., Maier, U., Brinkmann, A. M., and Schumm, F. 1985. Pyridostigmine kinetics in healthy subjects and patients with myasthenia gravis. Clin. Pharmacol. Ther. 37:495-501.
21. Breyer-Pfaff, U., Schmezer, A., Maier, U., Brinkmann, A., and Schumm, F. 1990. Neuromuscular function and plasma drug levels in pyridostigmine treatment of myasthenia gravis. J. Neurol. Neursurg. Psychiat. 53:502-506.
22. Chaney, L. A., Rockhold, R. W., Wineman, R. W., and Hume, A. S. 1999. Anticonvulsant-resistant seizures following pyridostigmine bromide (PB) and N,N-diethyl-m-toluamide (DEET). Toxicol. Sci. 49:306-311.
23. Consler, T. G., Persson, B. L., Jung, H., Zen, K. H., Jung, K., Prive, G. G., Verner, G. E., and Kaback, H. R. 1993. Properties and purification of an active biotinylated lactose permease from Escherichia coli. Proc. Natl. Acad. Sci. USA 90:6934-6938.
24. Edwards, D. L., and Johnson, C. E. 1987. Insect repellent-induced toxic encephalopathy in a child. Clin. Pharmacol. 6:496-498.
25. Ekins, S., Kim, R. B., Leake, B. F., Dantzig, A. H., Schuetz, E., Lan, L., Yasuda, K., Shepard, R. L., Winter, M. A., Schuetz, J. D., Wikel, J. H., and Wrighton, S. A. 2002. Three-dimensional quantitative structure-activity relationships of inhibitors of P-glycoprotein. Mol. Pharmacol. 61:964-973.
26. El-Masry, E. M., and Abou-Donia, M. B. 1999. Reversal of P-glycoprotein mediated multidrug resistance in Escherichia coli by chlorpromazine. Bull. Fac. Sci. Zag. Univ. 21:18-33.
27. El-Masry, E. M., and Abou-Donia, M. B. 2003. Reversal of P-glycoprotein expressed in Escherichia coli leaky mutant by ascorbic acid. Life Sci. 73:981-991.
28. El-Masry, E. M., Abdel-Salam, H. A., and Abou-Donia, M. B. 2002. Chlorpyrifos oxon induces P-glycoprotein expression in Escherichia coli mutant. Egy. J. Med. Microbiol. 11:861-868.
29. Galgani, F., Cornwall, R., Tommey, H., and Epel, D. D. 1996. Interaction of environmental xenobiotics with a multixenobiotic defense mechanism in the bay mussel, Mytilus galloprovincialis, from the coast of California. Environ. Toxicol. Chem. 15:325-331.
30. Germann, U. A., Willingham, M. C., Pastan, I., and Gottesman, M. M. 1990. Expression of the human multidrug transporter in insect cells by a recombinant baculovirus. Biochemistry 29:2295-2303.
31. Gottesman, M., and Pastan, I. 1993. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62:385-427.
32. Gryboski, J., Weinstein, D., and Ordaway, N. K. 1961. Toxic encephalopathy apparently related to the use of an insect repellent. N. Engl. J. Med. 264:289-291.
33. Higgins, C. F. 1994. Flip-flop: The transmembrane translocation of lipids. Cell 79:393-395.
34. Hrycyna, C., Ramachandra, M., Pastan, I., and Gottesman, M. M. 1998. Functional expression of human P-glycoprotein from plasmids using vaccinia virus-bacteriophage T7 RNA polymerase system. Methods Enzymol. 292:456-473.
35. Hsu, S. I., Lothstein, L., and Horwitz, S. B. 1989. Differential overexpression of three mdr gene family members in multidrug-resistant J7742 mouse cells: Evidence that distinct P-gp precursors are encoded unique mdr genes. J. Biol. Chem. 264:12053-12062.
36. Hussain, A. S., and Ritschel, W. A. 1988. Influence of dimethylacetamide, N-N-diethyl-m-toluamide and 1-dodecylazacycloheptan-2-one on ex vivo permeation of phosphonoformic acid through rat skin. Methods Find. Exp. Clin. Pharmacol. 10:691-694.
37. Jetté, L., Beaulieu, É., Leclerc, J. M., and Béliveau, R. 1996. Cyclosporine A treatment induces overexpression of P-glycoprotein in the kidney and other tissues. Am. J. Physiol. 270(Renal Fluid Electrolyte Physiol. 39):F756-F765.
38. Kuchler, K., and Thorner, J. 1992. Functional expression of human mdr1 in the yeast Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA 89:2302-2306.
39. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 277:680-685.
40. Lanning, C. L., Fine, R. L., Corcoran, J. J., Ayad, H. M., Rose, R. L., and Abou-Donia, M. B. 1996. Tobacco budworm P-glycoprotein: Biochemical characterization and its involvement in pesticide resistance. Biochim. Biophys. Acta 129:155-162.
41. Ling V. 1997. Multidrug resistance: molecular mechanisms and clinical relevance. Cancer Chemother. Pharmacol. 40(suppl.):S3-S8.
42. McCain, W. C., Lee, R., Johnson, M. S., Whaley, J. E., Ferguson, J. W., Beall, P., and Leach, G. 1997. Acute oral toxicity study of pyridostigmine bromide, permethrin, and DEET in the laboratory rat. J. Toxicol. Environ. Health 50:113-124.
43. McConnel, R., Fidler, A. T., and Chrislip, D. 1986. Health hazard evaluation determination, report no. 83-085. Washington, DC: NIOSH, U.S. Department of Health and Human Services.
44. Moss, J. I. 1996. Synergism of toxicity of N, N-diethyl-m-toluamide to German cockroaches (Orthoptera: Blattelidae) by hydrolytic enzyme inhibitors. J. Econ. Entomol. 89:1151-1155.
45. Persian Gulf Veterans Coordination Board. 1995. Unexplained illness among Desert Storm veterans. Arch. Intern. Med. 155:262-268.
46. Ramu, A., and Ramu, N. 1992. Reversal of multidrug resistance by phenothiazines and structurally related compounds. Cancer Chemother. Phramacol. 30:165-173.
47. Roland, E. H., Jan, J. E., and Rigg, J. M. 1985. Toxic encephalopathy in a child after brief exposure to insect repellents. Can. Med. Assoc. J. 132:155-156.
48. Sarkadi, B., Price, E., Boucher, R., Germann, U., and Scarborough, G. 1992. Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug stimulated membrane ATPase. J. Biol. Chem. 267:4854-4858.
49. Selim, S., Ralph, E., Hartnagel, T. G., Thomas, G., Osimitz, K. L., Schdewig, G., and Schoenig, G. P. 1995. Absorption and metabolism of DEET following dermal application to human volunteers. Fundam. Appl. Toxicol. 25:95-100.
50. Shapiro, A. B., and Ling, V. 1997. Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities. Eur. J. Biochem. 250:130-137.
51. Shapiro, A. B., Fox, K., Lam, P., and Ling, V. 1999. Stimulation of P-glycoprotein-mediated drug transport by prazosin and progesterone. Eur. J. Biochem. 259:841-850.
52. Simon, S. M., and Schindler, M. 1994. Cell biology mechanisms of multidrug resistance in tumors. Proc. Natl. Acad. Sci. USA 91:3497-3504.
53. Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, L. H., Provenzo, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., and Klenk, D. C. 1985. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150:76-85.
54. Snodgrass, H. L., Nelson, D. C., and Weeks, M. H. 1982. Dermal penetration and potential for placental transfer of the insect repellent, N-N-diethyl-m-toluamide. Am. Ind. Hyg. Assoc. J. 43:747-753.
55. Stein, W. D. 1997. Kinetics of the multidrug transporter (P-glycoprotein) and its reversal. Physiol. Rev. 77:545-590.
56. Thomas, H., and Coley, H. M. 2003. Overcoming multidrug resistance in cancer: An update on the clinical strategy of inhibiting P-glycoprotein. Cancer Control 159-165.
57. van Veen, H. W., and Konings, W. N. 1998. The ABC family of multidrug transporters in microorganisms. Biochim. Biophys. Acta 1365:31-36.
58. Veltri, J. C., Osmitz, T. G., Bradford, D. C., and Page, B. C. 1994. Retrospective analysis of the poison control centers resulting from exposure to the insect repellent N,N-diethyl-m-toluamide (DEET) from 1985 to 1989. Clin. Toxicol. 32:1-16.
59. Verschoyle, R. D., Brown, A. W., Nolan, C., Ray, D. E., and Lister, T. 1992. A comparison of the acute toxicity, neuropathology, and electrophysiology of N,N-diethyl-m-toluamide and N,N-dimethyl-2,2-diphenylacetamide in rats. Fundam. Appl. Toxicol. 18(1):79-88.
60. Windheuser, J. J., Haslam, J. L., Caldwell, L., and Shaffer, R. D. 1982. The use of N,N-diethyl-m-toluamide to enhance dermal and transdermal delivery of drugs. J. Pharm. Sci. 71:1211-1213.